News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,332 Results
Type
Article (41421)
Company Profile (263)
Press Release (690635)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (204875)
Career Advice (2033)
Deals (35601)
Drug Delivery (131)
Drug Development (81557)
Employer Resources (173)
FDA (16518)
Job Trends (14988)
News (346911)
Policy (32751)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2601)
Accelerated approval (52)
Adcomms (27)
Allergies (173)
Alliances (49585)
ALS (215)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (481)
Approvals (16934)
Artificial intelligence (681)
Autoimmune disease (310)
Automation (57)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (780)
Cancer (6060)
Cardiovascular disease (485)
Career advice (1727)
Career pathing (43)
CAR-T (340)
CDC (57)
Celiac Disease (3)
Cell therapy (923)
Cervical cancer (49)
Clinical research (71116)
Collaboration (2104)
Company closure (5)
Compensation (1426)
Complete response letters (82)
COVID-19 (2749)
CRISPR (111)
C-suite (1162)
Cystic fibrosis (154)
Data (8248)
Decentralized trials (3)
Denatured (28)
Depression (163)
Dermatology (92)
Diabetes (602)
Diagnostics (6974)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (331)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (292)
Earnings (92162)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120083)
Executive appointments (1094)
FDA (20335)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1759)
Gene editing (238)
Generative AI (56)
Gene therapy (729)
GLP-1 (1061)
Government (4739)
Grass and pollen (6)
Guidances (412)
Healthcare (19111)
HIV (81)
Huntington's disease (57)
IgA nephropathy (105)
Immunology and inflammation (291)
Immuno-oncology (98)
Indications (198)
Infectious disease (3100)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (300)
Interviews (319)
IPO (16672)
IRA (50)
Job creations (3648)
Job search strategy (1431)
JPM (58)
Kidney cancer (19)
Labor market (105)
Layoffs (566)
Leadership (40)
Legal (7953)
Liver cancer (102)
Longevity (33)
Lung cancer (811)
Lymphoma (442)
Machine learning (60)
Management (59)
Manufacturing (1076)
MASH (200)
Medical device (13950)
Medtech (14086)
Mergers & acquisitions (20195)
Metabolic disorders (1541)
mRNA (217)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (432)
Neuropsychiatric disorders (106)
Neuroscience (3364)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4532)
Now hiring (79)
Obesity (715)
Opinion (289)
Ovarian cancer (233)
Pain (258)
Pancreatic cancer (323)
Parkinson's disease (375)
Partnered (33)
Patents (610)
Patient recruitment (694)
Peanut (62)
People (59686)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22169)
Phase 2 (31334)
Phase 3 (23313)
Pipeline (9208)
Policy (322)
Postmarket research (2569)
Preclinical (9434)
Press Release (64)
Prostate cancer (322)
Psychedelics (54)
Radiopharmaceuticals (337)
Rare diseases (1098)
Real estate (5973)
Recruiting (70)
Regulatory (25537)
Reports (56)
Research institute (2417)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (179)
Series A (295)
Series B (215)
Service/supplier (11)
Sickle cell disease (115)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3643)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (87)
The Weekly (63)
Vaccines (1118)
Venture capital (112)
Weight loss (458)
Women's health (128)
Worklife (20)
Date
Today (196)
Last 7 days (805)
Last 30 days (3454)
Last 365 days (30257)
2026 (14051)
2025 (30172)
2024 (35210)
2023 (40072)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46536)
2018 (35017)
2017 (32107)
2016 (31487)
2015 (37556)
2014 (31320)
2013 (26349)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (354)
Arkansas (14)
Asia (39793)
Australia (6526)
California (13593)
Canada (3844)
China (1405)
Colorado (579)
Connecticut (592)
Delaware (417)
Europe (86080)
Florida (2030)
Georgia (435)
Hawaii (3)
Idaho (63)
Illinois (1096)
India (92)
Indiana (616)
Iowa (23)
Japan (558)
Kansas (132)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1625)
Massachusetts (9707)
Michigan (370)
Minnesota (733)
Mississippi (6)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3563)
New Mexico (29)
New York (3556)
North Carolina (1719)
North Dakota (9)
Northern California (6844)
Ohio (407)
Oklahoma (23)
Oregon (41)
Pennsylvania (2723)
Puerto Rico (29)
Rhode Island (50)
South America (1113)
South Carolina (86)
South Dakota (2)
Southern California (5370)
Tennessee (216)
Texas (2162)
United States (47903)
Utah (403)
Vermont (1)
Virginia (327)
Washington D.C. (81)
Washington State (1087)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
732,332 Results for "eddingpharm cayman inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Successful pilot scale run with Cayman Chemical validates eXoZymes’ technology and scalability
March 18, 2026
·
1 min read
Press Releases
Cayman Chemical and Curapath Partner to Provide Wider Access to PEG-Free Shielding Lipids for Lipid Nanoparticles
September 3, 2025
·
1 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
April 14, 2025
·
5 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
May 6, 2025
·
4 min read
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits.
February 20, 2024
·
2 min read
Cayman Chemical Receives CEP for Latanoprost API from EDQM
Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients
September 19, 2023
·
1 min read
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics.
July 11, 2023
·
4 min read
Policy
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China
Amarin Corporation plc announced that its commercial partner in China, EddingPharm, has received regulatory approval for VASCEPA® from China’s National Medical Products Administration.
June 1, 2023
·
9 min read
1 of 73,234
Next
